Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial

World Health Organization, 2009, New influenza A (H1N1) virus: global epidemiological situation, June 2009, Wkly Epidemiol Rec, 84, 249 Bishop, 2009, Australia's winter with the 2009 pandemic influenza A (H1N1) virus, N Engl J Med, 361, 2591, 10.1056/NEJMp0910445 Gomez, 2009, Pandemic influenza in a southern hemisphere setting: the experience in Peru from May to September, 2009, Euro Surveill, 14., 10.2807/ese.14.42.19371-en 2009, Update: influenza activity – United States, April–August 2009, MMWR Morb Mortal Wkly Rep, 58, 1009 World Health Organization. WHO. Pandemic (H1N1) 2009 – update 76. World Health Organization. 30-11-2009. 2009, Update: influenza activity – United States, August 30–October 31, 2009, MMWR Morb Mortal Wkly Rep, 58, 1236 Finelli, 2010 O’Riordan, 2009, Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza, CMAJ, 182, 39, 10.1503/cmaj.091724 2009, Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1 Plennevaux, 2009, Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials, Lancet, 375, 41, 10.1016/S0140-6736(09)62026-2 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2009, MMWR Recomm Rep, 58, 1 World Health Organization, 2009 CBER/FDA, 2009 Liang, 2010, Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial, Lancet, 375, 56, 10.1016/S0140-6736(09)62003-1 Zhu, 2009, A novel influenza A (H1N1) vaccine in various age groups, N Engl J Med, 361, 2414, 10.1056/NEJMoa0908535 Nolan, 2010, Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial, JAMA, 303, 37, 10.1001/jama.2009.1911 Carmona, 2010, Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months, Vaccine, 28, 5837, 10.1016/j.vaccine.2010.06.065 Oh, 2010, Safety and immunogenicity of an inactivated split-virus influenza A/H1N1 vaccine in healthy children from 6 months to <18 years of age: a prospective, open-label, multi-center trial, Vaccine, 28, 5857, 10.1016/j.vaccine.2010.06.060 Lu, 2010, Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents, Vaccine, 28, 5864, 10.1016/j.vaccine.2010.06.059 Arguedas, 2010, Responses to 2009 H1N1 vaccine in children 3 to 17 years of age, N Engl J Med, 362, 370, 10.1056/NEJMc0909988 Waddington, 2010, Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months–12 years: open label, randomised, parallel group, multicentre study, BMJ, 340, c2649, 10.1136/bmj.c2649 Miller, 2010, Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study, Lancet, 375, 1100, 10.1016/S0140-6736(09)62126-7 Pedroza, 2009, The safety and immunogenicity of influenza vaccine in children with asthma in Mexico, Int J Infect Dis, 13, 469, 10.1016/j.ijid.2008.08.015